跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial
Approved
STANDARD
DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial
Janssen-Cilag Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
078808e1a269cb24
Company
Janssen-Cilag Pty Ltd
Type
Standard
Approval Details
Approval Id
078808e1a269cb24
Product Name
DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial
Artg Id
322685
Artg Name
DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial
Sponsor
Janssen-Cilag Pty Ltd
Company Detail Path
/organization/janssen-cilag-pty-ltd
Artg Date
2020-09-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d0cfa90eb8f7844757d798c8f67e807d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/590bb55c154fea6236e523c12bc2eb70.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
078808e1a269cb24
Type
Standard
Back to TGA Approvals